Legal & General Group Plc Sells 14,524 Shares of Inspire Medical Systems, Inc. $INSP

Legal & General Group Plc decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 17.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 69,756 shares of the company’s stock after selling 14,524 shares during the quarter. Legal & General Group Plc’s holdings in Inspire Medical Systems were worth $6,434,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. Hantz Financial Services Inc. boosted its stake in Inspire Medical Systems by 194.0% during the 4th quarter. Hantz Financial Services Inc. now owns 685 shares of the company’s stock valued at $63,000 after purchasing an additional 452 shares during the period. Jefferies Financial Group Inc. bought a new stake in Inspire Medical Systems during the 4th quarter valued at approximately $28,369,000. Global Retirement Partners LLC boosted its stake in Inspire Medical Systems by 14,910.0% during the 4th quarter. Global Retirement Partners LLC now owns 3,002 shares of the company’s stock valued at $277,000 after purchasing an additional 2,982 shares during the period. Leonteq Securities AG bought a new stake in Inspire Medical Systems during the 4th quarter valued at approximately $732,000. Finally, Covestor Ltd boosted its stake in Inspire Medical Systems by 52.8% during the 4th quarter. Covestor Ltd now owns 2,677 shares of the company’s stock valued at $247,000 after purchasing an additional 925 shares during the period. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 2.1%

Shares of INSP stock opened at $41.29 on Friday. The stock has a 50 day moving average of $48.93 and a two-hundred day moving average of $73.29. Inspire Medical Systems, Inc. has a 12 month low of $38.91 and a 12 month high of $147.03. The company has a market capitalization of $1.19 billion, a P/E ratio of 9.20, a P/E/G ratio of 4.25 and a beta of 0.73.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.38. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The business had revenue of $204.58 million during the quarter, compared to analysts’ expectations of $200.04 million. During the same period in the prior year, the firm posted $0.10 EPS. Inspire Medical Systems’s quarterly revenue was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Sell-side analysts predict that Inspire Medical Systems, Inc. will post 0.91 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Truist Financial decreased their target price on Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating for the company in a research note on Tuesday, May 5th. Robert W. Baird reduced their price objective on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Weiss Ratings downgraded Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 6th. Mizuho reduced their price objective on Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating for the company in a research report on Tuesday, May 5th. Finally, Zacks Research downgraded Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a research report on Wednesday, May 13th. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.84.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.